1. Home
  2. MLAB vs ACHV Comparison

MLAB vs ACHV Comparison

Compare MLAB & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$128.45

Market Cap

719.9M

Sector

Industrials

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$7.92

Market Cap

726.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLAB
ACHV
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
719.9M
726.5M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
MLAB
ACHV
Price
$128.45
$7.92
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$94.00
$14.67
AVG Volume (30 Days)
107.9K
1.4M
Earning Date
05-27-2026
05-11-2026
Dividend Yield
0.67%
N/A
EPS Growth
436.11
N/A
EPS
0.49
N/A
Revenue
N/A
N/A
Revenue This Year
$6.07
N/A
Revenue Next Year
$5.41
N/A
P/E Ratio
$258.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$63.48
$2.62
52 Week High
$132.70
$8.64

Technical Indicators

Market Signals
Indicator
MLAB
ACHV
Relative Strength Index (RSI) 64.58 56.09
Support Level $94.20 $4.11
Resistance Level $132.70 $8.63
Average True Range (ATR) 4.19 0.38
MACD -0.55 -0.05
Stochastic Oscillator 75.66 55.83

Price Performance

Historical Comparison
MLAB
ACHV

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: